<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Rijt, L.S. van</title>
    <link>http://repub.eur.nl/res/aut/3238/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>T-cell regulation of neutrophil infiltrate at the early stages of a murine colitis model (Article)</title>
      <link>http://repub.eur.nl/res/pub/19241/</link>
      <pubDate>2010-02-26T00:00:00Z</pubDate>
      <description>Background: T-cells are a main target for antiinflammatory drugs in inflammatory bowel disease. As the innate immune system is also implicated in the pathogenesis of these diseases, T-cell suppressors may not only inhibit T-cell-dependent production of proinflammatory mediators but also affect innate immune cell function. Specifically, these drugs may impair innate immune cell recruitment and activation through inhibition of T-cells or act independent of T-cell modulation. We explored the extent of immune modulation by the T-cell inhibitor tacrolimus in a murine colitis model. Methods: We assessed the effects of tacrolimus on trinitro-benzene sulphonic acid (TNBS) colitis in wildtype and Rag2-deficient mice. The severity of colitis was assessed by means of histological scores and weight loss. We further characterized the inflammation using immunohistochemistry and by analysis of isolated intestinal leukocytes at various stages of disease. Results: Tacrolimus-treated wildtype mice were less sensitive to colitis and had fewer activated T-cells. Inhibition of T-cell function was associated with strongly diminished recruitment of infiltrating neutrophils in the colon at the early stages of this model. In agreement, immunohistochemistry demonstrated that tacrolimus inhibited production of the neutrophil chemoattractants CXCL1 and CXCL2. Rag2-deficient mice displayed an enhanced baseline level of lamina propria neutrophils that was moderately increased in TNBS colitis and remained unaffected by tacrolimus. Conclusions: Both the innate and the adaptive mucosal immune system contribute to TNBS colitis. Tacrolimus suppresses colitis directly through inhibition of T-cell activation and by suppression of T-cell-mediated recruitment of neutrophils.</description>
    </item> <item>
      <title>Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice (Article)</title>
      <link>http://repub.eur.nl/res/pub/25208/</link>
      <pubDate>2009-10-26T00:00:00Z</pubDate>
      <description>Tertiary lymphoid organs (TLOs) are organized aggregates of B and T cells formed in postem-bryonic life in response to chronic immune responses to infectious agents or self-antigens. Although CD11c+dendritic cells (DCs) are consistently found in regions of TLO, their contribution to TLO organization has not been studied in detail. We found that CD11chiDCs are essential for the maintenance of inducible bronchus-associated lymphoid tissue (iBALT), a form of TLO induced in the lungs after influenza virus infection. Elimination of DCs after the virus had been cleared from the lung resulted in iBALT disintegration and reduction in germinal center (GC) reactions, which led to significantly reduced numbers of class-switched plasma cells in the lung and bone marrow and reduction in protective antiviral serum immunoglobulins. Mechanistically, DCs isolated from the lungs of mice with iBALT no longer presented viral antigens to T cells but were a source of lymphotoxin (LT) β and homeostatic chemokines (CXCL-12 and -13 and CCL-19 and -21) known to contribute to TLO organization. Like depletion of DCs, blockade of LTβ receptor signaling after virus clearance led to disintegration of iBALT and GC reactions. Together, our data reveal a previously unappreciated function of lung DCs in iBALT homeostasis and humoral immunity to influenza virus. </description>
    </item> <item>
      <title>Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/28937/</link>
      <pubDate>2008-07-07T00:00:00Z</pubDate>
      <description>Although dendritic cells (DCs) play an important role in mediating protection against influenza virus, the precise role of lung DC subsets, such as CD11b-and CD11b+conventional DCs or plasmacytoid DCs (pDCs), in different lung compartments is currently unknown. Early after intranasal infection, tracheal CD11b-CD11chiDCs migrated to the mediastinal lymph nodes (MLNs), acquiring co-stimulatory molecules in the process. This emigration from the lung was followed by an accumulation of CD11b+CD11chiDCs in the trachea and lung interstitium. In the MLNs, the CD11b+DCs contained abundant viral nucleoprotein (NP), but these cells failed to present antigen to CD4 or CD8 T cells, whereas resident CD11b-CD8α+DCs presented to CD8 cells, and migratory CD11b-CD8α-DCs presented to CD4 and CD8 T cells. When lung CD11chiDCs and macrophages or langerin+CD11b-CD11chiDCs were depleted using either CD11c - diphtheria toxin receptor (DTR) or langerin-DTR mice, the development of virus-specif c CD8+T cells was severely delayed, which correlated with increased clinical severity and a delayed viral clearance. 120G8+CD11cintpDCs also accumulated in the lung and LNs carrying viral NP, but in their absence, there was no effect on viral clearance or clinical severity. Rather, in pDC-depleted mice, there was a reduction in antiviral antibody production after lung clearance of the virus. This suggests that multiple DCs are endowed with different tasks in mediating protection against influenza virus.</description>
    </item> <item>
      <title>Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection (Article)</title>
      <link>http://repub.eur.nl/res/pub/29134/</link>
      <pubDate>2008-02-18T00:00:00Z</pubDate>
      <description>The World Health Organization estimates that lower respiratory tract infections (excluding tuberculosis) account for ∼35% of all deaths caused by infectious diseases. In many cases, the cause of death may be caused by multiple pathogens, e.g., the life-threatening bacterial pneumonia observed in patients infected with influenza virus. The ability to evolve more efficient immunity on each successive encounter with antigen is the hallmark of the adaptive immune response. However, in the absence of cross-reactive T and B cell epitopes, one lung infection can modify immunity and pathology to the next for extended periods of time. We now report for the first time that this phenomenon is mediated by a sustained desensitization of lung sentinel cells to Toll-like receptor (TLR) ligands; this is an effect that lasts for several months after resolution of influenza or respiratory syncytial virus infection and is associated with reduced chemokine production and NF-κB activation in alveolar macrophages. Although such desensitization may be beneficial in alleviating overall immunopathology, the reduced neutrophil recruitment correlates with heightened bacterial load during secondary respiratory infection. Our data therefore suggests that post-viral desensitization to TLR signals may be one possible contributor to the common secondary bacterial pneumonia associated with pandemic and seasonal influenza infection. JEM </description>
    </item> <item>
      <title>Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/35228/</link>
      <pubDate>2007-09-01T00:00:00Z</pubDate>
      <description>Respiratory syncytial virus (RSV) is the primary cause of bronchiolitis in young children. Upon infection both T helper 1 (Th1) and Th2 cytokines are produced. Because RSV-induced Th2 responses have been associated with severe immunopathology and aggravation of allergic reactions, the regulation of the immune response following RSV infection is crucial. In this study we examined the influence of RSV on the activation and function of murine bone marrow-derived dendritic cells (DCs). RSV induced the expression of maturation markers on myeloid DCs (mDCs) in vitro. The mDCs stimulated with RSV and ovalbumin (OVA) enhanced proliferation of OVA-specific T cells, which produced both Th1 and Th2 cytokines. In contrast to mDCs, RSV did not induce the expression of maturation markers on plasmacytoid DCs (pDCs), not did it enhance the proliferation of OVA-specific T cells that were cocultured with pDCs. However, RSV stimulated the production of interferon-α (IFN-α) by pDCs. Our findings indicate a clear difference in the functional activation of DC subsets. RSV-stimulated mDCs may have immunostimulatory effects on both Th1 and Th2 responses, while RSV-stimulated pDCs have direct antiviral activity through the release of IFN-α. </description>
    </item> <item>
      <title>In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma (Article)</title>
      <link>http://repub.eur.nl/res/pub/8412/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>Although dendritic cells (DCs) play an important role in sensitization to
      inhaled allergens, their function in ongoing T helper (Th)2 cell-mediated
      eosinophilic airway inflammation underlying bronchial asthma is currently
      unknown. Here, we show in an ovalbumin (OVA)-driven murine asthma model
      that airway DCs acquire a mature phenotype and interact with CD4(+) T
      cells within sites of peribronchial and perivascular inflammation. To
      study whether DCs contributed to inflammation, we depleted DCs from the
      airways of CD11c-diphtheria toxin (DT) receptor transgenic mice during the
      OVA aerosol challenge. Airway administration of DT depleted CD11c(+) DCs
      and alveolar macrophages and abolished the characteristic features of
      asthma, including eosinophilic inflammation, goblet cell hyperplasia, and
      bronchial hyperreactivity. In the absence of CD11c(+) cells, endogenous or
      adoptively transferred CD4(+) Th2 cells did not produce interleukin
      (IL)-4, IL-5, and IL-13 in response to OVA aerosol. In CD11c-depleted
      mice, eosinophilic inflammation and Th2 cytokine secretion were restored
      by adoptive transfer of CD11c(+) DCs, but not alveolar macrophages. These
      findings identify lung DCs as key proinflammatory cells that are necessary
      and sufficient for Th2 cell stimulation during ongoing airway
      inflammation.</description>
    </item> <item>
      <title>Airway eosinophils accumulate in the mediastinal lymph nodes but lack antigen-presenting potential for naive T cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/10225/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Asthma is characterized by infiltration of the airway wall with
      eosinophils. Although eosinophils are considered to be effector cells,
      recent studies have reported their ability to activate primed Th2 cells.
      In this study, we investigated whether eosinophils are capable of
      presenting Ag to unprimed T cells in draining lymph nodes (DLN) of the
      lung and compared this capacity with professional dendritic cells (DC).
      During development of eosinophilic airway inflammation in OVA-sensitized
      and challenged mice, CCR3(+) eosinophils accumulated in the DLN. To study
      their function, eosinophils were isolated from the bronchoalveolar lavage
      fluid of mice by sorting on CCR3(+)B220(-)CD3(-)CD11c(dim) low
      autofluorescent cells, avoiding contamination with other APCs, and were
      intratracheally injected into mice that previously received CFSE-labeled
      OVA TCR-transgenic T cells. Eosinophils did not induce divisions of T
      cells in the DLN, whereas DC induced on average 3.7 divisions in 45.7% of
      T cells. To circumvent the need for Ag processing or migration in vivo,
      eosinophils were pulsed with OVA peptide and were still not able to induce
      T cell priming in vitro, whereas DC induced vigorous proliferation. This
      lack of Ag-presenting ability was explained by the very weak expression of
      MHC class II on fresh eosinophils, despite expression of the costimulatory
      molecules CD80 and ICAM-1. This investigation does not support any role
      for airway eosinophils as APCs to naive T cells, despite their migration
      to the DLN at times of allergen exposure. DC are clearly superior in
      activating T cells in the DLN of the lung.</description>
    </item> <item>
      <title>Allergen-induced accumulation of airway dendritic cells is supported by an increase in CD31(hi)Ly-6C(neg) bone marrow precursors in a mouse model of asthma (Article)</title>
      <link>http://repub.eur.nl/res/pub/8183/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>Airway dendritic cells (DCs) are held responsible for inducing
      sensitization to inhaled antigen, leading to eosinophilic airway
      inflammation, typical of asthma. However, less information is available
      about the role of these cells in ongoing inflammation. In a mouse model of
      asthma, sensitization to ovalbumin (OVA) was induced by intratracheal
      injection of myeloid OVA-pulsed DCs. Upon OVA aerosol challenge and
      induction of eosinophilic airway inflammation in sensitized mice, there
      was a time-dependent and almost 100-fold increase in the number of
      MHCII(+) CD11b(+) CD11c(+) endogenous airway DCs as well as CD11b(+) blood
      DCs. The mechanism of this increase was studied. Adoptive transfer
      experiments demonstrated that accumulation of airway DCs was not due to
      reduced migration to the mediastinal lymph nodes. Rather, the massive
      increase in airway and lymph node DCs was supported by an almost 3-fold
      expansion of myeloid CD31(hi)Ly-6C(neg) hematopoietic precursor cells in
      the bone marrow (BM). There was no change in any of the other 5
      populations revealed by CD31/Ly-6C staining. When these CD31(hi)Ly-6C(neg)
      BM precursors were sorted and grown in granulocyte
      macrophage-colony-stimulating factor, they differentiated into MHCII(+)
      CD11c(+) DCs. The same CD31(hi)Ly-6C(neg) precursors also expressed the
      eotaxin receptor CCR3 and differentiated into eosinophils when grown in
      interleukin 5. Serum levels of eotaxin were doubled in mice with
      inflammation. These findings in an animal model of asthma suggest that the
      BM increases its output of myeloid precursors to meet the enhanced demand
      for DCs and eosinophils in inflamed airways.</description>
    </item>
  </channel>
</rss>